Zivo Bioscience Analysis
Zivo Bioscience is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Zivo Bioscience delisted stock analysis is to determine its intrinsic value, which is an estimate of what Zivo Bioscience is worth, separate from its market price. There are two main types of Zivo Bioscience's stock analysis: fundamental analysis and technical analysis.
The Zivo Bioscience stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Zivo Bioscience is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Zivo Stock trading window is adjusted to America/New York timezone.
Zivo |
Zivo Stock Analysis Notes
About 25.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 5.33. Zivo Bioscience had not issued any dividends in recent years. The entity had 1:6 split on the 27th of October 2023. ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. ZIVO Bioscience, Inc. is based in Bloomfield Hills, Michigan. Zivo Bioscience operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 10 people. For more information please call the company at 248 452 9866 or visit https://www.zivobioscience.com.Zivo Bioscience Investment Alerts
| Zivo Bioscience is not yet fully synchronised with the market data | |
| Zivo Bioscience has some characteristics of a very speculative penny stock | |
| Zivo Bioscience has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (8.75 M) with profit before overhead, payroll, taxes, and interest of 20 K. | |
| Zivo Bioscience currently holds about 5.08 M in cash with (7.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.54. | |
| Roughly 25.0% of the company outstanding shares are owned by insiders |
Zivo Bioscience Upcoming and Recent Events
Earnings reports are used by Zivo Bioscience to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 12th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Zivo Bioscience Thematic Classifications
In addition to having Zivo Bioscience stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | Food ProductsUSA Equities from Food Products industry as classified by Fama & French |
Zivo Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 2 M.Zivo Bioscience Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Zivo Bioscience insiders, such as employees or executives, is commonly permitted as long as it does not rely on Zivo Bioscience's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Zivo Bioscience insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Strome Mark E over a year ago Conversion by Strome Mark E of 326286 shares of Zivo Bioscience |
Zivo Bioscience Outstanding Bonds
Zivo Bioscience issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Zivo Bioscience uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Zivo bonds can be classified according to their maturity, which is the date when Zivo Bioscience has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US98971DAB64 Corp BondUS98971DAB64 | View | |
| Dana 575 percent Corp BondUS235822AB96 | View | |
| ZOETIS INC 395 Corp BondUS98978VAM54 | View | |
| ZOETIS INC 39 Corp BondUS98978VAN38 | View | |
| ZOETIS INC 45 Corp BondUS98978VAK98 | View | |
| ZOETIS INC 3 Corp BondUS98978VAL71 | View | |
| ZOETIS INC Corp BondUS98978VAS25 | View | |
| ZOETIS INC 445 Corp BondUS98978VAP85 | View |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Zivo Bioscience to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Balance Of Power Now
Balance Of PowerCheck stock momentum by analyzing Balance Of Power indicator and other technical ratios |
| All Next | Launch Module |
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Zivo Stock
If you are still planning to invest in Zivo Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zivo Bioscience's history and understand the potential risks before investing.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |